Lyme disease vaccine 70 percent effective: Pfizer
#Lyme disease #vaccine #Pfizer #effectiveness #ticks #prevention #trials
📌 Key Takeaways
- Pfizer's Lyme disease vaccine shows 70% effectiveness in trials
- Vaccine targets Borrelia burgdorferi bacteria transmitted by ticks
- Potential to reduce Lyme disease cases in endemic regions
- Represents a significant advancement in tick-borne illness prevention
📖 Full Retelling
A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed the results from a phase 3 trial. If approved by regulators, it would be the only vaccine for humans against Lyme disease. “Lyme disease can cause potentially serious consequences – where individuals and families face...
🏷️ Themes
Health, Vaccines
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed the results from a phase 3 trial. If approved by regulators, it would be the only vaccine for humans against Lyme disease. “Lyme disease can cause potentially serious consequences – where individuals and families face...
Read full article at source